STAT News

STAT+: A journey to witness China’s biotech boom up close

Chinese-designed drugs now account for roughly half the global pipeline. STAT's Jason Mast traveled to Shanghai to get an up-close look at the competition that's making American's nervous.

Por STAT News

1 minuto de lectura
Compartir
STAT+: A journey to witness China’s biotech boom up close
STAT+: A journey to witness China’s biotech boom up close

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Health Tech

Perspectivas relacionadas